Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.

Autor:	Chen Y; Department of Physiology, Shenzhen University Medical School, Shenzhen, China.; Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China.; Graduate Program of Pharmaceutical Sciences, Shenzhen University Medical School, Shenzhen, China., Ying Y; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Ma W; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Ma H; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Shi L; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Gao X; Integrative Microecology Center, Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, China., Jia M; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Li M; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Song X; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Kong W; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Chen W; Department of Physiology, Shenzhen University Medical School, Shenzhen, China.; Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China., Zheng X; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Muluh TA; Department of Physiology, Shenzhen University Medical School, Shenzhen, China., Wang X; Southern University of Science and Technology Hospital, Shenzhen, China., Wang M; Department of Physiology, Shenzhen University Medical School, Shenzhen, China.; Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, China., Shu XS; Department of Physiology, Shenzhen University Medical School, Shenzhen, China.; Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China.; Graduate Program of Pharmaceutical Sciences, Shenzhen University Medical School, Shenzhen, China.
Jazyk:	angličtina
Zdroj:	Cancer research [Cancer Res] 2024 Apr 15; Vol. 84 (8), pp. 1237-1251.
DOI:	10.1158/0008-5472.CAN-23-1836
Abstrakt:	Epigenetic alterations at cis-regulatory elements (CRE) fine-tune transcriptional output. Epigenetic readers interact with CREs and can cooperate with other chromatin regulators to drive oncogene transcription. Here, we found that the YEATS domain-containing histone acetylation reader ENL (eleven-nineteen leukemia) acts as a key regulator of super-enhancers (SE), which are highly active distal CREs, across cancer types. ENL occupied the majority of SEs with substantially higher preference over typical enhancers, and the enrichment of ENL at SEs depended on its ability to bind acetylated histones. Rapid depletion of ENL by auxin-inducible degron tagging severely repressed the transcription of SE-controlled oncogenes, such as MYC, by inducing the decommissioning of their SEs, and restoring ENL protein expression largely reversed these effects. Additionally, ENL was indispensable for the rapid activation of SE-regulated immediate early genes in response to growth factor stimulation. Furthermore, ENL interacted with the histone chaperone FACT complex and was required for the deposition of FACT over CREs, which mediates nucleosome reorganization required for transcription initiation and elongation. Proper control of transcription by ENL and ENL-associated FACT was regulated by the histone reader BRD4. ENL was overexpressed in colorectal cancer and functionally contributed to colorectal cancer growth and metastasis. ENL degradation or inhibition synergized with BET inhibitors that target BRD4 in restraining colorectal cancer progression. These findings establish the essential role of epigenetic reader ENL in governing SE-driven oncogenic transcription and uncover the potential of ENL intervention to increase sensitivity to BET inhibition. Significance: ENL plays a key role in decoding epigenetic marks at highly active oncogenic super-enhancers and can be targeted in combination with BET inhibition as a promising synergistic strategy for optimizing cancer treatment. (©2024 American Association for Cancer Research.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu